BR9509590A - Aplicação de sod em liposomas - Google Patents

Aplicação de sod em liposomas

Info

Publication number: BR9509590A
Authority: BR; Brazil
Prior art keywords: sod; liposomes; application; rhsod; peyronie
Prior art date: 1994-11-04

Application number

BR9509590A

Other languages

English (en)

Inventor

Hermann Katinger

Karola Vorauer-Uhl

Eckhard Fuernschlief

Original Assignee

Polymun Scient Immunbio Forsch

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-04

Filing date

1995-11-06

Publication date

1997-12-23

1995-11-06 Application filed by Polymun Scient Immunbio Forsch filed Critical Polymun Scient Immunbio Forsch

1997-12-23 Publication of BR9509590A publication Critical patent/BR9509590A/pt

Links

239000002502 liposome Substances 0.000 title abstract 2
208000020758 Peyronie disease Diseases 0.000 abstract 2
102000019197 Superoxide Dismutase Human genes 0.000 abstract 2
108010012715 Superoxide dismutase Proteins 0.000 abstract 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
208000004362 Penile Induration Diseases 0.000 abstract 1
239000000654 additive Substances 0.000 abstract 1
230000007850 degeneration Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000003176 fibrotic effect Effects 0.000 abstract 1
239000000499 gel Substances 0.000 abstract 1
229920002674 hyaluronan Polymers 0.000 abstract 1
229960003160 hyaluronic acid Drugs 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000002674 ointment Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/25—Removal of unwanted matter, e.g. deodorisation or detoxification using enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Birds (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Food Science & Technology (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Dispersion Chemistry (AREA)
Polymers & Plastics (AREA)
Microbiology (AREA)
Nutrition Science (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BR9509590A 1994-11-04 1995-11-06 Aplicação de sod em liposomas BR9509590A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP94117409		1994-11-04
PCT/EP1995/004352 WO1996014083A1 (de)	1994-11-04	1995-11-06	Applikation von sod in liposomen

Publications (1)

Publication Number	Publication Date
BR9509590A true BR9509590A (pt)	1997-12-23

Family

ID=8216432

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9509590A BR9509590A (pt)	1994-11-04	1995-11-06	Aplicação de sod em liposomas

Country Status (12)

Country	Link
US (2)	US5942245A (pt)
EP (1)	EP0789584B1 (pt)
AT (1)	ATE205723T1 (pt)
AU (1)	AU690377B2 (pt)
BR (1)	BR9509590A (pt)
CA (1)	CA2204493C (pt)
DE (1)	DE59509624D1 (pt)
ES (1)	ES2163530T3 (pt)
MX (1)	MX9703184A (pt)
NZ (1)	NZ296098A (pt)
PT (1)	PT789584E (pt)
WO (1)	WO1996014083A1 (pt)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998013024A2 (en) *	1996-09-27	1998-04-02	Hyal Pharmaceutical Corporation	Hyaluronic drug delivery system
AU5595098A (en) *	1996-12-03	1998-06-29	Neurocrine Biosciences, Inc.	A6la5a12 polypeptides and polynucleotides and methods of use therefor
AU759264B2 (en) *	1998-05-27	2003-04-10	Euro-Celtique S.A.	Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
US7297344B1 (en)	1999-05-27	2007-11-20	Euro-Celtique, S.A.	Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
PT1180017E (pt) *	1999-05-27	2010-05-28	Euro Celtique Sa	Preparações com povidona-iodo para o tratamento de feridas
ATE289805T1 (de)	1999-05-27	2005-03-15	Euro Celtique Sa	Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
US7300667B1 (en)	1999-05-27	2007-11-27	Euro-Celtique, S.A.	Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US6344214B1 (en) *	1999-12-13	2002-02-05	Cyanotech Corporation	Method for retarding and ameliorating fever blisters and canker sores
US20030157161A1 (en) *	2001-05-01	2003-08-21	Angiotech Pharmaceuticals, Inc.	Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
JP2004529934A (ja) *	2001-05-01	2004-09-30	アンジオテックファーマシューティカルズ，インコーポレイテッド	抗微小管剤およびポリペプチドまたはポリサッカリドを含む組成物、ならびに炎症状態を処置するための医薬品の調製のためのそれらの組成物の使用
US20050123593A1 (en) *	2001-06-25	2005-06-09	Jonathan Thompson	Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
ES2411656T3 (es) *	2002-03-13	2013-07-08	Thomas SKÖLD	Sistemas de administración a base de agua
US20030232784A1 (en) *	2002-06-14	2003-12-18	Benedict James J.	Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
US8709003B2 (en)	2003-02-25	2014-04-29	Tria Beauty, Inc.	Capacitive sensing method and device for detecting skin
EP2604215B1 (en)	2003-02-25	2017-10-11	Tria Beauty, Inc.	Eye-safe dermatologic treatment apparatus and method
US20040253344A1 (en) *	2003-04-11	2004-12-16	Novozymes A/S	Dairy product comprising hyaluronic acid
WO2004089098A1 (en) *	2003-04-11	2004-10-21	Novozymes A/S	Dairy product comprising hyaluronic acid
UA83504C2 (en) *	2003-09-04	2008-07-25	Селджин Корпорейшн	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
US20050186261A1 (en)	2004-01-30	2005-08-25	Angiotech International Ag	Compositions and methods for treating contracture
JP5376761B2 (ja) *	2004-02-23	2013-12-25	ストラテジックサイエンスアンドテクノロジーズ，エルエルシー	身体の外観および皮膚の外観を改善するための、一酸化窒素の局所送達
US8777935B2 (en)	2004-02-25	2014-07-15	Tria Beauty, Inc.	Optical sensor and method for identifying the presence of skin
US9226909B2 (en)	2004-04-19	2016-01-05	Strategic Science & Technologies, Llc	Beneficial effects of increasing local blood flow
JP2007532697A (ja) *	2004-04-19	2007-11-15	ストラテジックサイエンスアンドテクノロジーズ，エルエルシー	局所的血流増大の有益な効果
US8524274B2 (en)	2004-10-18	2013-09-03	Polymun Scientific Immunbiologische Forschung Gmbh	Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and the therapeutic use thereof
US20090104254A1 (en)	2004-12-22	2009-04-23	Rutgers, The State University Of New Jersey	Controlled Release Hydrogels
WO2012050591A1 (en)	2010-10-15	2012-04-19	Rutgers, The State University Of New Jersey	Hydrogel formulation for dermal and ocular delivery
US20070077258A1 (en) *	2005-03-29	2007-04-05	Guilford F T	ADMINISTRATION OF GLUTATHIONE (REDUCED) VIA INTRAVENOUS OR ENCAPSULATED IN LIPOSOME FOR THE AMELIORATION OF TNF-alpha EFFECTS AND FLU-LIKE VIRAL SYMPTOMS AND TREATMENT AND PREVENTION OF VIRUS
WO2006116452A1 (en) *	2005-04-22	2006-11-02	Molecular Regenix, Llc	Nutritional composition comprising hyaluronic acid and superoxide dismutase and methods of making and using same
ITPD20050146A1 (it)	2005-05-20	2006-11-21	Fidia Farmaceutici	Fillers riassorbibili costituiti da liposomi e acido ialuronico e o suoi derivati
US20070078375A1 (en) *	2005-09-30	2007-04-05	Transcutaneous Technologies Inc.	Iontophoretic delivery of active agents conjugated to nanoparticles
US7848801B2 (en)	2005-12-30	2010-12-07	Tti Ellebeau, Inc.	Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
US20070154403A1 (en) *	2006-01-05	2007-07-05	Thomas Skold	Oral, Pulmonary and Transmucosal Delivery Composition
US20080145415A1 (en) *	2006-04-21	2008-06-19	Lanfranco Callegaro	Bioresorbable Fillers Constituted by Phospholipid Liposomes and Hyaluronic Acid and/or the Derivatives Thereof
EP2073819B1 (en) *	2006-05-02	2016-12-28	University of Miami	Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds
JPWO2008087803A1 (ja) *	2007-01-16	2010-05-06	国立大学法人北海道大学	抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
JP2010187707A (ja) *	2007-06-12	2010-09-02	Hokkaido Univ	インスリンを封入したイオントフォレーシス用リポソーム製剤
WO2009132355A1 (en)	2008-04-25	2009-10-29	Tria Beauty, Inc.	Optical sensor and method for identifying the presence of skin and the pigmentation of skin
US20100196343A1 (en) *	2008-09-16	2010-08-05	O'neil Michael P	Compositions, methods, devices, and systems for skin care
US9072659B2 (en)	2009-06-24	2015-07-07	Strategic Science & Technologies, Llc	Topical composition containing naproxen
ES2607476T3 (es)	2009-06-24	2017-03-31	Strategic Science & Technologies, Llc	Composición tópica que contiene ibuprofeno
US12138268B2 (en)	2009-06-24	2024-11-12	Strategic Science & Technologies, Llc	Treatment of erectile dysfunction and other indications
US11684624B2 (en)	2009-06-24	2023-06-27	Strategic Science & Technologies, Llc	Treatment of erectile dysfunction and other indications
US8465413B2 (en)	2010-11-25	2013-06-18	Coloplast A/S	Method of treating Peyronie's disease
JP2014504592A (ja)	2010-12-29	2014-02-24	ストラテジックサイエンスアンドテクノロジーズ，エルエルシー	勃起不全および他の適応症の処置
JP2014501283A (ja)	2010-12-29	2014-01-20	ストラテジックサイエンスアンドテクノロジーズ，エルエルシー	アレルギーおよび他の適応症の処置のためのシステムおよび方法
EP2601965A1 (en)	2011-12-06	2013-06-12	Apeiron Biologics AG	Compositions for preventing or treating adverse reactions of EGFR inhibition
EP3269372B1 (en) *	2012-01-19	2019-06-12	Hybrid Medical, LLC	Topical therapeutic formulations
US10471131B2 (en)	2012-01-19	2019-11-12	Hybrid Medical, Llc	Topical therapeutic formulations
US20150010606A1 (en) *	2013-07-08	2015-01-08	Arthrex, Inc.	Intra-articular injection and implant attachment of molecule consisting of lubricin and extracellular superoxide dismutase or hyaluronic acid and extracellular superoxide dismutase
WO2016118281A1 (en)	2015-01-20	2016-07-28	TetraDerm Group LLC	Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration
PT3316857T (pt)	2015-06-30	2021-11-03	Sequessome Tech Holdings Limited	Composições multifásicas
DE102016100330A1 (de) *	2016-01-11	2017-07-13	Germany Bergmann Biomedicine Gmbh	Neuer Typ von medizinischem Strahlungsschutzspray
KR102682716B1 (ko)	2017-05-17	2024-07-08	비피지바이오, 인크.	수포성 표피박리증의 치료 및 예방에서 조효소 q10 제형의 용도
KR102157645B1 (ko)	2018-09-12	2020-09-18	정철민	캡슐화된 수퍼옥사이드 디스뮤타아제를 함유하는 화장료 조성물의 제조방법.
CN110917403A (zh) *	2019-12-10	2020-03-27	河南亚都实业有限公司	一种组织工程皮肤支架材料及制备方法
US20210346471A1 (en) *	2020-04-30	2021-11-11	Danny C Purser	Superoxide dismutase compositions and methods

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4235871A (en) *	1978-02-24	1980-11-25	Papahadjopoulos Demetrios P	Method of encapsulating biologically active materials in lipid vesicles
US5710033A (en) *	1983-10-03	1998-01-20	Chiron Corporation	Superoxide dismutase cloning and expression in microorganisms
LU85910A1 (fr) *	1985-05-22	1986-12-05	Oleofina Sa	Procede pour eliminer l'oxygene dans les aliments et les boissons,et composition enzymatique utilisee a cet effet
DK402785D0 (da) *	1985-09-03	1985-09-03	Syn Tek Ab	Fremgangsmaade til fremstilling af et enzym
JPS6377824A (ja) *	1986-09-19	1988-04-08	Tosoh Corp	外用ゲル化製剤
JPH01319427A (ja) *	1988-06-22	1989-12-25	Yutaka Mizushima	スーパーオキシドジスムターゼを含む局所投与用製薬組成物
US5185154A (en) *	1989-02-02	1993-02-09	Liposome Technology, Inc.	Method for instant preparation of a drug containing large unilamellar vesicles
CA2045550A1 (en) *	1989-11-09	1991-05-10	Koichiro Miyajima	Glucosamine derivative and liposome containing the same as membrane constituent
JP3283288B2 (ja) *	1991-03-08	2002-05-20	電気化学工業株式会社	生理活性ペプチド製剤
DK0580817T3 (da) *	1991-04-19	1996-08-05	Nexstar Pharmaceuticals Inc	Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
US5116616A (en) *	1991-04-29	1992-05-26	Bio-Technology General Corp.	Use of intratracheal administration of SOD to protect humans from lung injury due to hyperoxia and hyperventilation
EP0587055B1 (de) *	1992-09-09	2001-12-05	Bio-Technology General Corporation	Verwendung von Mangan-Superoxiddismutase (Mn-SOD) zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen in niedriger Dosierung
FR2721208B1 (fr) *	1994-06-16	1996-08-02	Oreal	Composition à usage topique contenant un antioxidant et un extrait bactérien, et utilisation de cette composition.

1995
- 1995-11-06 MX MX9703184A patent/MX9703184A/es unknown
- 1995-11-06 NZ NZ296098A patent/NZ296098A/en not_active IP Right Cessation
- 1995-11-06 WO PCT/EP1995/004352 patent/WO1996014083A1/de not_active Ceased
- 1995-11-06 EP EP95938419A patent/EP0789584B1/de not_active Expired - Lifetime
- 1995-11-06 DE DE59509624T patent/DE59509624D1/de not_active Expired - Lifetime
- 1995-11-06 CA CA002204493A patent/CA2204493C/en not_active Expired - Lifetime
- 1995-11-06 ES ES95938419T patent/ES2163530T3/es not_active Expired - Lifetime
- 1995-11-06 US US08/836,185 patent/US5942245A/en not_active Expired - Lifetime
- 1995-11-06 BR BR9509590A patent/BR9509590A/pt not_active Application Discontinuation
- 1995-11-06 PT PT95938419T patent/PT789584E/pt unknown
- 1995-11-06 AT AT95938419T patent/ATE205723T1/de active
- 1995-11-06 AU AU39816/95A patent/AU690377B2/en not_active Expired
1999
- 1999-06-07 US US09/327,174 patent/US6312720B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NZ296098A (en)	2001-05-25
ES2163530T3 (es)	2002-02-01
AU3981695A (en)	1996-05-31
DE59509624D1 (de)	2001-10-25
WO1996014083A1 (de)	1996-05-17
EP0789584B1 (de)	2001-09-19
CA2204493C (en)	2009-04-14
US6312720B1 (en)	2001-11-06
CA2204493A1 (en)	1996-05-17
AU690377B2 (en)	1998-04-23
US5942245A (en)	1999-08-24
EP0789584A1 (de)	1997-08-20
ATE205723T1 (de)	2001-10-15
MX9703184A (es)	1997-12-31
PT789584E (pt)	2002-03-28

Publication	Publication Date	Title
BR9509590A (pt)	1997-12-23	Aplicação de sod em liposomas
US4512978A (en)	1985-04-23	Dermatological composition useful in the treatment of psoriasis
BR0108173A (pt)	2003-01-21	Composições farmacêuticas de toxina de botulina
GR880100578A (en)	1989-06-22	Ophthalmological cyclosporine composition and preparation method
UA41989C2 (uk)	2001-10-15	Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
BRPI0011640B8 (pt)	2021-05-25	ácidos aldônicos de oligossacarídeo e seu uso tópico
PT716600E (pt)	2002-09-30	Composicoes para administracao topica contendo derivados do acido 3-benzoilfenilacetico para o tratamento de doencas inflamatorias oftalmicas
CA2180454A1 (en)	1996-05-17	External preparation for skin protection
TR199701490A2 (xx)	1998-06-22	3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
ATE336997T1 (de)	2006-09-15	Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
HUP9602498A2 (hu)	1998-04-28	Antimikrobiális hatású gyógyászati készítmények
AU2101800A (en)	2000-07-31	Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
DK284386A (da)	1986-12-19	Farmaceutisk praeparat mod hudlidelser
TR200002078T2 (tr)	2000-11-21	Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
ATE292117T1 (de)	2005-04-15	Zusammensetzungen zur behandlung von hautkrankheiten
ATE172117T1 (de)	1998-10-15	Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
JPH08505388A (ja)	1996-06-11	ヒアルロン酸−尿素医薬組成物およびその使用
JPS61129106A (ja)	1986-06-17	皮膚親和性化粧用組成物
DE69919597D1 (de)	2004-09-23	Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung
RU2092156C1 (ru)	1997-10-10	Раствор для стимуляции репарации кожи "коллагель"
GEP20032968B (en)	2003-05-27	Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis
KR880005920A (ko)	1988-07-21	인체의 백혈구 인터페론 조성물과 피부 치료법
TR199900013T2 (xx)	1999-04-21	Yeni bile�ikler.
RU2088239C1 (ru)	1997-08-27	Состав, проникающий через кожу, для лечения остеоартроза
JPH08143447A (ja)	1996-06-04	入浴剤

Legal Events

Date	Code	Title	Description
2004-06-22	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2006-01-10	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2007-04-10	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2007-12-26	B09B	Patent application refused [chapter 9.2 patent gazette]
2018-03-27	B15K	Others concerning applications: alteration of classification	Ipc: A61K 9/00 (2006.01), A23L 5/20 (2016.0